Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 10Non-Muscle Invasive Bladder Neoplasms 7Peritoneal Neoplasms 3Colorectal Neoplasms 3Carcinoma, Transitional Cell 3Appendiceal Neoplasms 3Anus Neoplasms 2Urothelial Carcinoma of the Bladder 1Urologic Neoplasms 1Urologic Diseases 1Urogenital Neoplasms 1Urogenital Diseases 1Urinary Bladder Diseases 1Rectal Neoplasms 1Pseudomyxoma Peritonei 1Peritoneal Diseases 1Ovarian Neoplasms 1Neoplasms by Site 1Neoplasms 1Necrosis 1Male Urogenital Diseases 1HIV Infections 1Gastrointestinal Neoplasms 1Female Urogenital Diseases 1Anal Canal Carcinoma 1

Interventions

Mitomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Peritoneal Diseases × Mitomycin × 90 days × Clear all
NCT07487168 2026-05-15

Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Not yet recruiting
24 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Diseases, Peritoneal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡